Baxter International Inc. has initiated a voluntary nationwide recall for two lots of its 0.9% Sodium Chloride Injection due to the potential presence of fiberglass particulate matter identified within the solution.\n\nThe intravenous administration of this solution containing fiberglass can lead to serious adverse health consequences. These include blockages and clotting in blood vessels, which may cut off blood flow to vital organs, potentially causing a life-threatening pulmonary embolism, permanent organ damage, or even death.\n\nAdditionally, the particles may cause local vein irritation, inflammatory reactions, aggravate preexisting infections, and trigger allergic responses. As of August 25, 2026, Baxter has not received any reports of adverse events related to this issue.
